nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiagabine—SLC6A1—GABA synthesis, release, reuptake and degradation—HSPA8—stomach cancer	0.00164	0.144	CbGpPWpGaD
Tiagabine—SLC6A1—Neurotransmitter Release Cycle—HSPA8—stomach cancer	0.000871	0.0766	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—BLVRB—stomach cancer	0.000835	0.0734	CbGpPWpGaD
Tiagabine—Rhinitis—Epirubicin—stomach cancer	0.000489	0.000494	CcSEcCtD
Tiagabine—Conjunctivitis—Doxorubicin—stomach cancer	0.000488	0.000494	CcSEcCtD
Tiagabine—Urinary tract infection—Doxorubicin—stomach cancer	0.000488	0.000494	CcSEcCtD
Tiagabine—Haemorrhage—Epirubicin—stomach cancer	0.000488	0.000493	CcSEcCtD
Tiagabine—Diarrhoea—Fluorouracil—stomach cancer	0.000487	0.000492	CcSEcCtD
Tiagabine—Thrombocytopenia—Capecitabine—stomach cancer	0.000487	0.000492	CcSEcCtD
Tiagabine—Tinnitus—Methotrexate—stomach cancer	0.000486	0.000491	CcSEcCtD
Tiagabine—Tachycardia—Capecitabine—stomach cancer	0.000485	0.000491	CcSEcCtD
Tiagabine—Hypoaesthesia—Epirubicin—stomach cancer	0.000485	0.000491	CcSEcCtD
Tiagabine—Pharyngitis—Epirubicin—stomach cancer	0.000484	0.000489	CcSEcCtD
Tiagabine—Sweating—Doxorubicin—stomach cancer	0.000482	0.000487	CcSEcCtD
Tiagabine—Hyperhidrosis—Capecitabine—stomach cancer	0.000481	0.000486	CcSEcCtD
Tiagabine—Oedema peripheral—Epirubicin—stomach cancer	0.00048	0.000486	CcSEcCtD
Tiagabine—Hypotension—Docetaxel—stomach cancer	0.00048	0.000485	CcSEcCtD
Tiagabine—Haematuria—Doxorubicin—stomach cancer	0.000479	0.000485	CcSEcCtD
Tiagabine—Epistaxis—Doxorubicin—stomach cancer	0.000474	0.000479	CcSEcCtD
Tiagabine—Anorexia—Capecitabine—stomach cancer	0.000474	0.000479	CcSEcCtD
Tiagabine—Vomiting—Irinotecan—stomach cancer	0.000472	0.000478	CcSEcCtD
Tiagabine—Sinusitis—Doxorubicin—stomach cancer	0.000471	0.000477	CcSEcCtD
Tiagabine—Dizziness—Fluorouracil—stomach cancer	0.000471	0.000476	CcSEcCtD
Tiagabine—Visual impairment—Epirubicin—stomach cancer	0.00047	0.000475	CcSEcCtD
Tiagabine—Rash—Irinotecan—stomach cancer	0.000468	0.000474	CcSEcCtD
Tiagabine—Dermatitis—Irinotecan—stomach cancer	0.000468	0.000473	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000468	0.000473	CcSEcCtD
Tiagabine—Chills—Methotrexate—stomach cancer	0.000467	0.000473	CcSEcCtD
Tiagabine—Headache—Irinotecan—stomach cancer	0.000465	0.000471	CcSEcCtD
Tiagabine—Hypotension—Capecitabine—stomach cancer	0.000465	0.00047	CcSEcCtD
Tiagabine—Insomnia—Docetaxel—stomach cancer	0.000464	0.00047	CcSEcCtD
Tiagabine—Paraesthesia—Docetaxel—stomach cancer	0.000461	0.000466	CcSEcCtD
Tiagabine—Alopecia—Methotrexate—stomach cancer	0.00046	0.000466	CcSEcCtD
Tiagabine—Dyspnoea—Docetaxel—stomach cancer	0.000458	0.000463	CcSEcCtD
Tiagabine—Somnolence—Docetaxel—stomach cancer	0.000457	0.000462	CcSEcCtD
Tiagabine—Tinnitus—Epirubicin—stomach cancer	0.000455	0.00046	CcSEcCtD
Tiagabine—Haemoglobin—Doxorubicin—stomach cancer	0.000453	0.000459	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000453	0.000458	CcSEcCtD
Tiagabine—Vomiting—Fluorouracil—stomach cancer	0.000452	0.000458	CcSEcCtD
Tiagabine—Rhinitis—Doxorubicin—stomach cancer	0.000452	0.000457	CcSEcCtD
Tiagabine—Dyspepsia—Docetaxel—stomach cancer	0.000452	0.000457	CcSEcCtD
Tiagabine—Haemorrhage—Doxorubicin—stomach cancer	0.000451	0.000456	CcSEcCtD
Tiagabine—Insomnia—Capecitabine—stomach cancer	0.00045	0.000455	CcSEcCtD
Tiagabine—Hypoaesthesia—Doxorubicin—stomach cancer	0.000449	0.000454	CcSEcCtD
Tiagabine—Rash—Fluorouracil—stomach cancer	0.000449	0.000454	CcSEcCtD
Tiagabine—Dermatitis—Fluorouracil—stomach cancer	0.000448	0.000453	CcSEcCtD
Tiagabine—Pharyngitis—Doxorubicin—stomach cancer	0.000448	0.000453	CcSEcCtD
Tiagabine—Paraesthesia—Capecitabine—stomach cancer	0.000446	0.000452	CcSEcCtD
Tiagabine—Decreased appetite—Docetaxel—stomach cancer	0.000446	0.000452	CcSEcCtD
Tiagabine—Headache—Fluorouracil—stomach cancer	0.000446	0.000451	CcSEcCtD
Tiagabine—Oedema peripheral—Doxorubicin—stomach cancer	0.000444	0.00045	CcSEcCtD
Tiagabine—Dysgeusia—Methotrexate—stomach cancer	0.000444	0.000449	CcSEcCtD
Tiagabine—Dyspnoea—Capecitabine—stomach cancer	0.000443	0.000448	CcSEcCtD
Tiagabine—Fatigue—Docetaxel—stomach cancer	0.000443	0.000448	CcSEcCtD
Tiagabine—Nausea—Irinotecan—stomach cancer	0.000441	0.000446	CcSEcCtD
Tiagabine—Constipation—Docetaxel—stomach cancer	0.000439	0.000444	CcSEcCtD
Tiagabine—Pain—Docetaxel—stomach cancer	0.000439	0.000444	CcSEcCtD
Tiagabine—Back pain—Methotrexate—stomach cancer	0.000439	0.000444	CcSEcCtD
Tiagabine—Dyspepsia—Capecitabine—stomach cancer	0.000438	0.000443	CcSEcCtD
Tiagabine—Chills—Epirubicin—stomach cancer	0.000437	0.000442	CcSEcCtD
Tiagabine—Visual impairment—Doxorubicin—stomach cancer	0.000435	0.00044	CcSEcCtD
Tiagabine—Decreased appetite—Capecitabine—stomach cancer	0.000432	0.000437	CcSEcCtD
Tiagabine—Alopecia—Epirubicin—stomach cancer	0.000431	0.000436	CcSEcCtD
Tiagabine—Fatigue—Capecitabine—stomach cancer	0.000429	0.000434	CcSEcCtD
Tiagabine—Constipation—Capecitabine—stomach cancer	0.000425	0.00043	CcSEcCtD
Tiagabine—Pain—Capecitabine—stomach cancer	0.000425	0.00043	CcSEcCtD
Tiagabine—Feeling abnormal—Docetaxel—stomach cancer	0.000423	0.000428	CcSEcCtD
Tiagabine—Nausea—Fluorouracil—stomach cancer	0.000423	0.000427	CcSEcCtD
Tiagabine—Ill-defined disorder—Methotrexate—stomach cancer	0.000421	0.000426	CcSEcCtD
Tiagabine—Tinnitus—Doxorubicin—stomach cancer	0.000421	0.000425	CcSEcCtD
Tiagabine—Gastrointestinal pain—Docetaxel—stomach cancer	0.00042	0.000425	CcSEcCtD
Tiagabine—Anaemia—Methotrexate—stomach cancer	0.000419	0.000424	CcSEcCtD
Tiagabine—Flatulence—Epirubicin—stomach cancer	0.000418	0.000423	CcSEcCtD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—SLC1A2—stomach cancer	0.000418	0.0368	CbGpPWpGaD
Tiagabine—Tension—Epirubicin—stomach cancer	0.000416	0.000421	CcSEcCtD
Tiagabine—Dysgeusia—Epirubicin—stomach cancer	0.000416	0.00042	CcSEcCtD
Tiagabine—Nervousness—Epirubicin—stomach cancer	0.000412	0.000417	CcSEcCtD
Tiagabine—Back pain—Epirubicin—stomach cancer	0.000411	0.000415	CcSEcCtD
Tiagabine—Feeling abnormal—Capecitabine—stomach cancer	0.00041	0.000414	CcSEcCtD
Tiagabine—Malaise—Methotrexate—stomach cancer	0.000409	0.000414	CcSEcCtD
Tiagabine—Muscle spasms—Epirubicin—stomach cancer	0.000408	0.000413	CcSEcCtD
Tiagabine—Vertigo—Methotrexate—stomach cancer	0.000407	0.000412	CcSEcCtD
Tiagabine—Gastrointestinal pain—Capecitabine—stomach cancer	0.000407	0.000411	CcSEcCtD
Tiagabine—Body temperature increased—Docetaxel—stomach cancer	0.000406	0.000411	CcSEcCtD
Tiagabine—Abdominal pain—Docetaxel—stomach cancer	0.000406	0.000411	CcSEcCtD
Tiagabine—Leukopenia—Methotrexate—stomach cancer	0.000406	0.000411	CcSEcCtD
Tiagabine—Chills—Doxorubicin—stomach cancer	0.000405	0.000409	CcSEcCtD
Tiagabine—SLC6A1—Monoamine Transport—IL1B—stomach cancer	0.000399	0.0351	CbGpPWpGaD
Tiagabine—Alopecia—Doxorubicin—stomach cancer	0.000399	0.000403	CcSEcCtD
Tiagabine—Cough—Methotrexate—stomach cancer	0.000396	0.0004	CcSEcCtD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—CLCN3—stomach cancer	0.000396	0.0348	CbGpPWpGaD
Tiagabine—Urticaria—Capecitabine—stomach cancer	0.000395	0.0004	CcSEcCtD
Tiagabine—Ill-defined disorder—Epirubicin—stomach cancer	0.000394	0.000398	CcSEcCtD
Tiagabine—Abdominal pain—Capecitabine—stomach cancer	0.000393	0.000398	CcSEcCtD
Tiagabine—Body temperature increased—Capecitabine—stomach cancer	0.000393	0.000398	CcSEcCtD
Tiagabine—Anaemia—Epirubicin—stomach cancer	0.000392	0.000397	CcSEcCtD
Tiagabine—Agitation—Epirubicin—stomach cancer	0.00039	0.000395	CcSEcCtD
Tiagabine—SLC6A1—NRF2 pathway—TGFA—stomach cancer	0.000389	0.0342	CbGpPWpGaD
Tiagabine—Flatulence—Doxorubicin—stomach cancer	0.000387	0.000391	CcSEcCtD
Tiagabine—Arthralgia—Methotrexate—stomach cancer	0.000386	0.000391	CcSEcCtD
Tiagabine—Chest pain—Methotrexate—stomach cancer	0.000386	0.000391	CcSEcCtD
Tiagabine—Myalgia—Methotrexate—stomach cancer	0.000386	0.000391	CcSEcCtD
Tiagabine—Tension—Doxorubicin—stomach cancer	0.000385	0.00039	CcSEcCtD
Tiagabine—Dysgeusia—Doxorubicin—stomach cancer	0.000385	0.000389	CcSEcCtD
Tiagabine—SLC6A1—NRF2 pathway—SERPINA1—stomach cancer	0.000383	0.0337	CbGpPWpGaD
Tiagabine—Malaise—Epirubicin—stomach cancer	0.000383	0.000387	CcSEcCtD
Tiagabine—Discomfort—Methotrexate—stomach cancer	0.000381	0.000386	CcSEcCtD
Tiagabine—Nervousness—Doxorubicin—stomach cancer	0.000381	0.000386	CcSEcCtD
Tiagabine—Vertigo—Epirubicin—stomach cancer	0.000381	0.000386	CcSEcCtD
Tiagabine—Syncope—Epirubicin—stomach cancer	0.000381	0.000385	CcSEcCtD
Tiagabine—Leukopenia—Epirubicin—stomach cancer	0.00038	0.000384	CcSEcCtD
Tiagabine—Back pain—Doxorubicin—stomach cancer	0.00038	0.000384	CcSEcCtD
Tiagabine—Hypersensitivity—Docetaxel—stomach cancer	0.000378	0.000383	CcSEcCtD
Tiagabine—Muscle spasms—Doxorubicin—stomach cancer	0.000378	0.000382	CcSEcCtD
Tiagabine—Palpitations—Epirubicin—stomach cancer	0.000375	0.000379	CcSEcCtD
Tiagabine—Confusional state—Methotrexate—stomach cancer	0.000373	0.000377	CcSEcCtD
Tiagabine—Loss of consciousness—Epirubicin—stomach cancer	0.000373	0.000377	CcSEcCtD
Tiagabine—Cough—Epirubicin—stomach cancer	0.00037	0.000375	CcSEcCtD
Tiagabine—Asthenia—Docetaxel—stomach cancer	0.000368	0.000373	CcSEcCtD
Tiagabine—Infection—Methotrexate—stomach cancer	0.000368	0.000372	CcSEcCtD
Tiagabine—Hypertension—Epirubicin—stomach cancer	0.000366	0.000371	CcSEcCtD
Tiagabine—Hypersensitivity—Capecitabine—stomach cancer	0.000366	0.000371	CcSEcCtD
Tiagabine—Ill-defined disorder—Doxorubicin—stomach cancer	0.000364	0.000369	CcSEcCtD
Tiagabine—Pruritus—Docetaxel—stomach cancer	0.000363	0.000368	CcSEcCtD
Tiagabine—Anaemia—Doxorubicin—stomach cancer	0.000363	0.000367	CcSEcCtD
Tiagabine—Thrombocytopenia—Methotrexate—stomach cancer	0.000362	0.000367	CcSEcCtD
Tiagabine—Arthralgia—Epirubicin—stomach cancer	0.000361	0.000365	CcSEcCtD
Tiagabine—Chest pain—Epirubicin—stomach cancer	0.000361	0.000365	CcSEcCtD
Tiagabine—Myalgia—Epirubicin—stomach cancer	0.000361	0.000365	CcSEcCtD
Tiagabine—Agitation—Doxorubicin—stomach cancer	0.000361	0.000365	CcSEcCtD
Tiagabine—Anxiety—Epirubicin—stomach cancer	0.00036	0.000364	CcSEcCtD
Tiagabine—Hyperhidrosis—Methotrexate—stomach cancer	0.000358	0.000362	CcSEcCtD
Tiagabine—Discomfort—Epirubicin—stomach cancer	0.000357	0.000361	CcSEcCtD
Tiagabine—Asthenia—Capecitabine—stomach cancer	0.000357	0.000361	CcSEcCtD
Tiagabine—Malaise—Doxorubicin—stomach cancer	0.000354	0.000358	CcSEcCtD
Tiagabine—Dry mouth—Epirubicin—stomach cancer	0.000353	0.000357	CcSEcCtD
Tiagabine—Vertigo—Doxorubicin—stomach cancer	0.000353	0.000357	CcSEcCtD
Tiagabine—Anorexia—Methotrexate—stomach cancer	0.000353	0.000357	CcSEcCtD
Tiagabine—Syncope—Doxorubicin—stomach cancer	0.000352	0.000356	CcSEcCtD
Tiagabine—Pruritus—Capecitabine—stomach cancer	0.000352	0.000356	CcSEcCtD
Tiagabine—Leukopenia—Doxorubicin—stomach cancer	0.000352	0.000356	CcSEcCtD
Tiagabine—Diarrhoea—Docetaxel—stomach cancer	0.000351	0.000355	CcSEcCtD
Tiagabine—SLC6A1—NRF2 pathway—CYP2A6—stomach cancer	0.000351	0.0308	CbGpPWpGaD
Tiagabine—Confusional state—Epirubicin—stomach cancer	0.000349	0.000353	CcSEcCtD
Tiagabine—Palpitations—Doxorubicin—stomach cancer	0.000347	0.000351	CcSEcCtD
Tiagabine—Oedema—Epirubicin—stomach cancer	0.000346	0.00035	CcSEcCtD
Tiagabine—Hypotension—Methotrexate—stomach cancer	0.000346	0.00035	CcSEcCtD
Tiagabine—Loss of consciousness—Doxorubicin—stomach cancer	0.000345	0.000349	CcSEcCtD
Tiagabine—Infection—Epirubicin—stomach cancer	0.000344	0.000348	CcSEcCtD
Tiagabine—Cough—Doxorubicin—stomach cancer	0.000343	0.000347	CcSEcCtD
Tiagabine—Shock—Epirubicin—stomach cancer	0.000341	0.000345	CcSEcCtD
Tiagabine—Diarrhoea—Capecitabine—stomach cancer	0.00034	0.000344	CcSEcCtD
Tiagabine—Dizziness—Docetaxel—stomach cancer	0.00034	0.000343	CcSEcCtD
Tiagabine—Thrombocytopenia—Epirubicin—stomach cancer	0.000339	0.000343	CcSEcCtD
Tiagabine—Hypertension—Doxorubicin—stomach cancer	0.000339	0.000343	CcSEcCtD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—SLC1A2—stomach cancer	0.000339	0.0298	CbGpPWpGaD
Tiagabine—Tachycardia—Epirubicin—stomach cancer	0.000338	0.000342	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000337	0.000341	CcSEcCtD
Tiagabine—Hyperhidrosis—Epirubicin—stomach cancer	0.000335	0.000339	CcSEcCtD
Tiagabine—Insomnia—Methotrexate—stomach cancer	0.000335	0.000339	CcSEcCtD
Tiagabine—Chest pain—Doxorubicin—stomach cancer	0.000334	0.000338	CcSEcCtD
Tiagabine—Arthralgia—Doxorubicin—stomach cancer	0.000334	0.000338	CcSEcCtD
Tiagabine—Myalgia—Doxorubicin—stomach cancer	0.000334	0.000338	CcSEcCtD
Tiagabine—Anxiety—Doxorubicin—stomach cancer	0.000333	0.000337	CcSEcCtD
Tiagabine—Paraesthesia—Methotrexate—stomach cancer	0.000332	0.000336	CcSEcCtD
Tiagabine—Discomfort—Doxorubicin—stomach cancer	0.00033	0.000334	CcSEcCtD
Tiagabine—Anorexia—Epirubicin—stomach cancer	0.00033	0.000334	CcSEcCtD
Tiagabine—Dyspnoea—Methotrexate—stomach cancer	0.00033	0.000334	CcSEcCtD
Tiagabine—Somnolence—Methotrexate—stomach cancer	0.000329	0.000333	CcSEcCtD
Tiagabine—Dizziness—Capecitabine—stomach cancer	0.000329	0.000333	CcSEcCtD
Tiagabine—Dry mouth—Doxorubicin—stomach cancer	0.000327	0.000331	CcSEcCtD
Tiagabine—Vomiting—Docetaxel—stomach cancer	0.000327	0.00033	CcSEcCtD
Tiagabine—Dyspepsia—Methotrexate—stomach cancer	0.000326	0.00033	CcSEcCtD
Tiagabine—Rash—Docetaxel—stomach cancer	0.000324	0.000328	CcSEcCtD
Tiagabine—Hypotension—Epirubicin—stomach cancer	0.000324	0.000327	CcSEcCtD
Tiagabine—Dermatitis—Docetaxel—stomach cancer	0.000323	0.000327	CcSEcCtD
Tiagabine—Confusional state—Doxorubicin—stomach cancer	0.000323	0.000327	CcSEcCtD
Tiagabine—Decreased appetite—Methotrexate—stomach cancer	0.000322	0.000325	CcSEcCtD
Tiagabine—Headache—Docetaxel—stomach cancer	0.000322	0.000325	CcSEcCtD
Tiagabine—Oedema—Doxorubicin—stomach cancer	0.00032	0.000324	CcSEcCtD
Tiagabine—SLC6A1—Neuronal System—SLC1A2—stomach cancer	0.00032	0.0282	CbGpPWpGaD
Tiagabine—Fatigue—Methotrexate—stomach cancer	0.000319	0.000323	CcSEcCtD
Tiagabine—Infection—Doxorubicin—stomach cancer	0.000318	0.000322	CcSEcCtD
Tiagabine—Pain—Methotrexate—stomach cancer	0.000317	0.00032	CcSEcCtD
Tiagabine—Vomiting—Capecitabine—stomach cancer	0.000316	0.00032	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000316	0.000319	CcSEcCtD
Tiagabine—Shock—Doxorubicin—stomach cancer	0.000315	0.000319	CcSEcCtD
Tiagabine—Thrombocytopenia—Doxorubicin—stomach cancer	0.000314	0.000317	CcSEcCtD
Tiagabine—Rash—Capecitabine—stomach cancer	0.000313	0.000317	CcSEcCtD
Tiagabine—Insomnia—Epirubicin—stomach cancer	0.000313	0.000317	CcSEcCtD
Tiagabine—Dermatitis—Capecitabine—stomach cancer	0.000313	0.000317	CcSEcCtD
Tiagabine—Tachycardia—Doxorubicin—stomach cancer	0.000313	0.000316	CcSEcCtD
Tiagabine—Headache—Capecitabine—stomach cancer	0.000311	0.000315	CcSEcCtD
Tiagabine—Paraesthesia—Epirubicin—stomach cancer	0.000311	0.000315	CcSEcCtD
Tiagabine—Hyperhidrosis—Doxorubicin—stomach cancer	0.00031	0.000313	CcSEcCtD
Tiagabine—Dyspnoea—Epirubicin—stomach cancer	0.000309	0.000312	CcSEcCtD
Tiagabine—Somnolence—Epirubicin—stomach cancer	0.000308	0.000311	CcSEcCtD
Tiagabine—Anorexia—Doxorubicin—stomach cancer	0.000306	0.000309	CcSEcCtD
Tiagabine—Nausea—Docetaxel—stomach cancer	0.000305	0.000309	CcSEcCtD
Tiagabine—Feeling abnormal—Methotrexate—stomach cancer	0.000305	0.000309	CcSEcCtD
Tiagabine—Dyspepsia—Epirubicin—stomach cancer	0.000305	0.000308	CcSEcCtD
Tiagabine—Gastrointestinal pain—Methotrexate—stomach cancer	0.000303	0.000306	CcSEcCtD
Tiagabine—Decreased appetite—Epirubicin—stomach cancer	0.000301	0.000305	CcSEcCtD
Tiagabine—Hypotension—Doxorubicin—stomach cancer	0.000299	0.000303	CcSEcCtD
Tiagabine—Fatigue—Epirubicin—stomach cancer	0.000299	0.000302	CcSEcCtD
Tiagabine—Pain—Epirubicin—stomach cancer	0.000296	0.0003	CcSEcCtD
Tiagabine—Constipation—Epirubicin—stomach cancer	0.000296	0.0003	CcSEcCtD
Tiagabine—Nausea—Capecitabine—stomach cancer	0.000295	0.000299	CcSEcCtD
Tiagabine—Urticaria—Methotrexate—stomach cancer	0.000294	0.000297	CcSEcCtD
Tiagabine—Body temperature increased—Methotrexate—stomach cancer	0.000293	0.000296	CcSEcCtD
Tiagabine—Abdominal pain—Methotrexate—stomach cancer	0.000293	0.000296	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000292	0.000295	CcSEcCtD
Tiagabine—Insomnia—Doxorubicin—stomach cancer	0.00029	0.000293	CcSEcCtD
Tiagabine—SLC6A1—Monoamine Transport—TNF—stomach cancer	0.00029	0.0255	CbGpPWpGaD
Tiagabine—Paraesthesia—Doxorubicin—stomach cancer	0.000288	0.000291	CcSEcCtD
Tiagabine—Dyspnoea—Doxorubicin—stomach cancer	0.000286	0.000289	CcSEcCtD
Tiagabine—Feeling abnormal—Epirubicin—stomach cancer	0.000285	0.000289	CcSEcCtD
Tiagabine—Somnolence—Doxorubicin—stomach cancer	0.000285	0.000288	CcSEcCtD
Tiagabine—Gastrointestinal pain—Epirubicin—stomach cancer	0.000283	0.000287	CcSEcCtD
Tiagabine—Dyspepsia—Doxorubicin—stomach cancer	0.000282	0.000285	CcSEcCtD
Tiagabine—Decreased appetite—Doxorubicin—stomach cancer	0.000279	0.000282	CcSEcCtD
Tiagabine—SLC6A1—NRF2 pathway—HBEGF—stomach cancer	0.000277	0.0244	CbGpPWpGaD
Tiagabine—Fatigue—Doxorubicin—stomach cancer	0.000276	0.000279	CcSEcCtD
Tiagabine—Urticaria—Epirubicin—stomach cancer	0.000275	0.000278	CcSEcCtD
Tiagabine—Pain—Doxorubicin—stomach cancer	0.000274	0.000277	CcSEcCtD
Tiagabine—Constipation—Doxorubicin—stomach cancer	0.000274	0.000277	CcSEcCtD
Tiagabine—Abdominal pain—Epirubicin—stomach cancer	0.000274	0.000277	CcSEcCtD
Tiagabine—Body temperature increased—Epirubicin—stomach cancer	0.000274	0.000277	CcSEcCtD
Tiagabine—Hypersensitivity—Methotrexate—stomach cancer	0.000273	0.000276	CcSEcCtD
Tiagabine—Asthenia—Methotrexate—stomach cancer	0.000266	0.000269	CcSEcCtD
Tiagabine—CYP3A4—Benzo(a)pyrene metabolism—AKR1C3—stomach cancer	0.000265	0.0233	CbGpPWpGaD
Tiagabine—Feeling abnormal—Doxorubicin—stomach cancer	0.000264	0.000267	CcSEcCtD
Tiagabine—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000262	0.000265	CcSEcCtD
Tiagabine—Pruritus—Methotrexate—stomach cancer	0.000262	0.000265	CcSEcCtD
Tiagabine—Hypersensitivity—Epirubicin—stomach cancer	0.000255	0.000258	CcSEcCtD
Tiagabine—Urticaria—Doxorubicin—stomach cancer	0.000255	0.000258	CcSEcCtD
Tiagabine—Body temperature increased—Doxorubicin—stomach cancer	0.000253	0.000256	CcSEcCtD
Tiagabine—Abdominal pain—Doxorubicin—stomach cancer	0.000253	0.000256	CcSEcCtD
Tiagabine—Diarrhoea—Methotrexate—stomach cancer	0.000253	0.000256	CcSEcCtD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—HSPA8—stomach cancer	0.00025	0.022	CbGpPWpGaD
Tiagabine—Asthenia—Epirubicin—stomach cancer	0.000249	0.000251	CcSEcCtD
Tiagabine—SLC6A1—NRF2 pathway—GSTP1—stomach cancer	0.000246	0.0216	CbGpPWpGaD
Tiagabine—Pruritus—Epirubicin—stomach cancer	0.000245	0.000248	CcSEcCtD
Tiagabine—Dizziness—Methotrexate—stomach cancer	0.000245	0.000248	CcSEcCtD
Tiagabine—SLC6A1—NRF2 pathway—HMOX1—stomach cancer	0.000242	0.0213	CbGpPWpGaD
Tiagabine—Diarrhoea—Epirubicin—stomach cancer	0.000237	0.00024	CcSEcCtD
Tiagabine—Hypersensitivity—Doxorubicin—stomach cancer	0.000236	0.000239	CcSEcCtD
Tiagabine—Vomiting—Methotrexate—stomach cancer	0.000235	0.000238	CcSEcCtD
Tiagabine—Rash—Methotrexate—stomach cancer	0.000233	0.000236	CcSEcCtD
Tiagabine—Dermatitis—Methotrexate—stomach cancer	0.000233	0.000236	CcSEcCtD
Tiagabine—Headache—Methotrexate—stomach cancer	0.000232	0.000235	CcSEcCtD
Tiagabine—Asthenia—Doxorubicin—stomach cancer	0.00023	0.000233	CcSEcCtD
Tiagabine—Dizziness—Epirubicin—stomach cancer	0.000229	0.000232	CcSEcCtD
Tiagabine—Pruritus—Doxorubicin—stomach cancer	0.000227	0.000229	CcSEcCtD
Tiagabine—SLC6A1—NRF2 pathway—GSTM1—stomach cancer	0.000226	0.0199	CbGpPWpGaD
Tiagabine—Vomiting—Epirubicin—stomach cancer	0.00022	0.000223	CcSEcCtD
Tiagabine—Nausea—Methotrexate—stomach cancer	0.00022	0.000222	CcSEcCtD
Tiagabine—Diarrhoea—Doxorubicin—stomach cancer	0.000219	0.000222	CcSEcCtD
Tiagabine—Rash—Epirubicin—stomach cancer	0.000218	0.000221	CcSEcCtD
Tiagabine—Dermatitis—Epirubicin—stomach cancer	0.000218	0.000221	CcSEcCtD
Tiagabine—Headache—Epirubicin—stomach cancer	0.000217	0.000219	CcSEcCtD
Tiagabine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—stomach cancer	0.000215	0.0189	CbGpPWpGaD
Tiagabine—Dizziness—Doxorubicin—stomach cancer	0.000212	0.000214	CcSEcCtD
Tiagabine—Nausea—Epirubicin—stomach cancer	0.000206	0.000208	CcSEcCtD
Tiagabine—Vomiting—Doxorubicin—stomach cancer	0.000204	0.000206	CcSEcCtD
Tiagabine—Rash—Doxorubicin—stomach cancer	0.000202	0.000204	CcSEcCtD
Tiagabine—Dermatitis—Doxorubicin—stomach cancer	0.000202	0.000204	CcSEcCtD
Tiagabine—Headache—Doxorubicin—stomach cancer	0.000201	0.000203	CcSEcCtD
Tiagabine—CYP3A4—Constitutive Androstane Receptor Pathway—PPP2R4—stomach cancer	0.0002	0.0176	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—HSPA8—stomach cancer	0.000191	0.0168	CbGpPWpGaD
Tiagabine—Nausea—Doxorubicin—stomach cancer	0.00019	0.000193	CcSEcCtD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLC1A2—stomach cancer	0.000172	0.0152	CbGpPWpGaD
Tiagabine—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—stomach cancer	0.000172	0.0151	CbGpPWpGaD
Tiagabine—CYP3A4—Xenobiotics—CYP2A6—stomach cancer	0.000144	0.0126	CbGpPWpGaD
Tiagabine—CYP3A4—Tamoxifen metabolism—CYP2A6—stomach cancer	0.000138	0.0122	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—PRKCB—stomach cancer	0.000136	0.012	CbGpPWpGaD
Tiagabine—CYP3A4—Tryptophan metabolism—ECHS1—stomach cancer	0.000113	0.00997	CbGpPWpGaD
Tiagabine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—stomach cancer	0.000112	0.00987	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—PRKCB—stomach cancer	0.000104	0.00918	CbGpPWpGaD
Tiagabine—CYP3A4—Estrogen metabolism—GSTM1—stomach cancer	0.000101	0.00887	CbGpPWpGaD
Tiagabine—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—stomach cancer	9.87e-05	0.00868	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—ALB—stomach cancer	9.17e-05	0.00807	CbGpPWpGaD
Tiagabine—CYP3A4—Irinotecan Pathway—APC—stomach cancer	9.15e-05	0.00805	CbGpPWpGaD
Tiagabine—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—stomach cancer	8.12e-05	0.00714	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—HMOX1—stomach cancer	7.76e-05	0.00683	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—MAPK1—stomach cancer	7.02e-05	0.00617	CbGpPWpGaD
Tiagabine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—stomach cancer	5.97e-05	0.00525	CbGpPWpGaD
Tiagabine—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—stomach cancer	5.89e-05	0.00518	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—APOA1—stomach cancer	5.88e-05	0.00518	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—HRAS—stomach cancer	5.63e-05	0.00496	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—MAPK1—stomach cancer	5.38e-05	0.00473	CbGpPWpGaD
Tiagabine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—stomach cancer	4.84e-05	0.00426	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—ALB—stomach cancer	4.66e-05	0.0041	CbGpPWpGaD
Tiagabine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—stomach cancer	4.34e-05	0.00382	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—HRAS—stomach cancer	4.32e-05	0.0038	CbGpPWpGaD
Tiagabine—CYP3A4—Biological oxidations—GSTT1—stomach cancer	2.6e-05	0.00229	CbGpPWpGaD
Tiagabine—CYP3A4—Biological oxidations—CYP2A6—stomach cancer	2.57e-05	0.00226	CbGpPWpGaD
Tiagabine—CYP3A4—Metapathway biotransformation—AKR1C3—stomach cancer	2.47e-05	0.00217	CbGpPWpGaD
Tiagabine—CYP3A4—Biological oxidations—GSTP1—stomach cancer	1.8e-05	0.00159	CbGpPWpGaD
Tiagabine—CYP3A4—Metapathway biotransformation—GSTP1—stomach cancer	1.78e-05	0.00156	CbGpPWpGaD
Tiagabine—CYP3A4—Biological oxidations—GSTM1—stomach cancer	1.66e-05	0.00146	CbGpPWpGaD
Tiagabine—CYP3A4—Metapathway biotransformation—GSTM1—stomach cancer	1.63e-05	0.00144	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ACAD8—stomach cancer	1.55e-05	0.00136	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GMPR2—stomach cancer	1.38e-05	0.00122	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—IDH3B—stomach cancer	1.26e-05	0.00111	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—SUCLG1—stomach cancer	1.26e-05	0.00111	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—NDUFV1—stomach cancer	1.17e-05	0.00103	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—NDUFS1—stomach cancer	1.17e-05	0.00103	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PGLS—stomach cancer	1.05e-05	0.000921	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—BLVRB—stomach cancer	1.05e-05	0.000921	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PPAP2A—stomach cancer	9.99e-06	0.000879	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—FBP1—stomach cancer	8.9e-06	0.000783	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—NDUFA2—stomach cancer	8.9e-06	0.000783	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CKB—stomach cancer	8.9e-06	0.000783	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CA1—stomach cancer	8.9e-06	0.000783	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PLIN2—stomach cancer	8.37e-06	0.000736	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CA2—stomach cancer	8.14e-06	0.000716	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—NT5E—stomach cancer	7.93e-06	0.000698	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PGAM1—stomach cancer	7.93e-06	0.000698	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PLCE1—stomach cancer	7.57e-06	0.000666	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ALDH7A1—stomach cancer	7.57e-06	0.000666	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—UMPS—stomach cancer	7.26e-06	0.000638	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ECHS1—stomach cancer	6.75e-06	0.000593	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PDHA1—stomach cancer	6.75e-06	0.000593	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—TYMP—stomach cancer	6.34e-06	0.000558	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—FADS1—stomach cancer	6.34e-06	0.000558	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—SREBF2—stomach cancer	5.94e-06	0.000522	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—RORA—stomach cancer	5.87e-06	0.000516	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ALDOB—stomach cancer	5.5e-06	0.000484	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ALOX5—stomach cancer	5.11e-06	0.00045	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—DPYD—stomach cancer	5.03e-06	0.000442	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GSTT1—stomach cancer	4.45e-06	0.000391	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CYP2A6—stomach cancer	4.4e-06	0.000387	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—AKR1C3—stomach cancer	4.28e-06	0.000376	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ENO1—stomach cancer	4.17e-06	0.000367	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CD44—stomach cancer	3.7e-06	0.000325	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PPP2R1A—stomach cancer	3.14e-06	0.000276	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GSTP1—stomach cancer	3.08e-06	0.000271	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—HMOX1—stomach cancer	3.04e-06	0.000267	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—TYMS—stomach cancer	2.87e-06	0.000252	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GSTM1—stomach cancer	2.83e-06	0.000249	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ERCC2—stomach cancer	2.66e-06	0.000234	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—MTHFR—stomach cancer	2.5e-06	0.00022	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CAV1—stomach cancer	2.31e-06	0.000203	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—APOA1—stomach cancer	2.3e-06	0.000203	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PPARG—stomach cancer	2.03e-06	0.000179	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ALB—stomach cancer	1.83e-06	0.000161	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—NOS3—stomach cancer	1.75e-06	0.000154	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PTGS2—stomach cancer	1.6e-06	0.00014	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PIK3CA—stomach cancer	9.83e-07	8.64e-05	CbGpPWpGaD
